Search research articles
Contact Us
Filters
Showing results (201-210 of 235) with videos related to
Page
of 24
Sort By:
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 16, 2024
PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
Dean F Wong, Ganesh B Chand, Nicole Caito, et al.
Archives of Neurology
|
February 16, 2011
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults
Jitka Sojkova, Ira Driscoll, Diego Iacono, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2007
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET
Dean F Wong, James R Brasić, Harvey S Singer, et al.
Bioconjugate Chemistry
|
September 15, 2023
Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System
Martin R Edelmann, Christoph Bredack, Sara Belli, et al.
Brain Imaging and Behavior
|
January 13, 2021
Imaging-based indices of Neuropathology and gait speed decline in older adults: the atherosclerosis risk in communities study
Kevin J Sullivan, Radhikesh Ranadive, Dan Su, et al.
Synapse (New York, N.Y.)
|
January 14, 2009
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers
James Robert Brasić, Yun Zhou, John L Musachio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 4, 2024
Social relationships, amyloid burden, and dementia: The ARIC-PET study
Renée C Groechel, Albert C Liu, Chelsea Liu, et al.
Parkinsonism & Related Disorders
|
May 5, 2019
Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease
Gwenn S Smith, Kelly A Mills, Greg M Pontone, et al.
Brain Sciences
|
December 1, 2020
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
James R Brašić, Ayon Nandi, David S Russell, et al.
Brain Sciences
|
March 25, 2022
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
James Robert Brašić, Jack Alexander Goodman, Ayon Nandi, et al.
Page
of 24
Search research articles
Search
Showing results (201-210 of 235) with videos related to
Sort By:
Page
of 24
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
October 16, 2024
PET clinical study of novel antipsychotic LB-102 demonstrates unexpectedly prolonged dopamine receptor target engagement
Dean F Wong, Ganesh B Chand, Nicole Caito, et al.
Archives of Neurology
|
February 16, 2011
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults
Jitka Sojkova, Ira Driscoll, Diego Iacono, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
November 8, 2007
Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET
Dean F Wong, James R Brasić, Harvey S Singer, et al.
Bioconjugate Chemistry
|
September 15, 2023
Evaluation of Tetrazine Tracers for Pretargeted Imaging within the Central Nervous System
Martin R Edelmann, Christoph Bredack, Sara Belli, et al.
Brain Imaging and Behavior
|
January 13, 2021
Imaging-based indices of Neuropathology and gait speed decline in older adults: the atherosclerosis risk in communities study
Kevin J Sullivan, Radhikesh Ranadive, Dan Su, et al.
Synapse (New York, N.Y.)
|
January 14, 2009
Single photon emission computed tomography experience with (S)-5-[(123)I]iodo-3-(2-azetidinylmethoxy)pyridine in the living human brain of smokers and nonsmokers
James Robert Brasić, Yun Zhou, John L Musachio, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 4, 2024
Social relationships, amyloid burden, and dementia: The ARIC-PET study
Renée C Groechel, Albert C Liu, Chelsea Liu, et al.
Parkinsonism & Related Disorders
|
May 5, 2019
Effect of STN DBS on vesicular monoamine transporter 2 and glucose metabolism in Parkinson's disease
Gwenn S Smith, Kelly A Mills, Greg M Pontone, et al.
Brain Sciences
|
December 1, 2020
Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome
James R Brašić, Ayon Nandi, David S Russell, et al.
Brain Sciences
|
March 25, 2022
Fragile X Mental Retardation Protein and Cerebral Expression of Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome: A Pilot Study
James Robert Brašić, Jack Alexander Goodman, Ayon Nandi, et al.
Page
of 24